Grafix: cost and payments to doctors
What Medicare Part D paid pharmacies for Grafix, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Smith+Nephew?
Smith+Nephew reported the most payments naming Grafix. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $5.4M
- Providers
- 8,615
- Transactions
- 25,650
- Average per transaction
- $212
The per-transaction average — $212 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,615 providers the average total is $632, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Smith+Nephew | $4,763,044 | 87.5% |
| Osiris Therapeutics Inc. | $673,827 | 12.4% |
| Linvatec Corporation | $8,983 | 0.2% |
Other products from Smith+Nephew
The company that reported the most payments naming Grafix also reports against these.
- Journey II$49,222,295
- Engage Partial Knee System$43,525,192
- EVOS$39,210,041
- TRIGEN InterTAN$20,250,975
- REAL INTELLIGENCE$20,227,275
- Q-FIX$18,455,719
- Journey II BCS$11,128,986
- Healicoil$10,632,451
- TRIGEN Femoral (FAN/TAN/Meta Nail)$8,908,003
- FOOTPRINT$7,470,438